Correlation Between Conduit Pharmaceuticals and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Viracta Therapeutics, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Viracta Therapeutics.
Diversification Opportunities for Conduit Pharmaceuticals and Viracta Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Conduit and Viracta is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Conduit Pharmaceuticals and Viracta Therapeutics
Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 7.36 times more return on investment than Viracta Therapeutics. However, Conduit Pharmaceuticals is 7.36 times more volatile than Viracta Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 14.00 in Conduit Pharmaceuticals on September 12, 2024 and sell it today you would lose (12.93) from holding Conduit Pharmaceuticals or give up 92.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 35.56% |
| Values | Daily Returns |
Conduit Pharmaceuticals vs. Viracta Therapeutics
Performance |
| Timeline |
| Conduit Pharmaceuticals |
| Viracta Therapeutics |
Conduit Pharmaceuticals and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Conduit Pharmaceuticals and Viracta Therapeutics
The main advantage of trading using opposite Conduit Pharmaceuticals and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Conduit Pharmaceuticals vs. Equillium | Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Valneva SE ADR | Conduit Pharmaceuticals vs. Vivani Medical |
| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |